Diiodohydroxyquinoline (Diodoquin) from Canada
Diiodohydroxyquinoline, also known as Diodoquin, is an anti-infective quinoline derivative specifically enumerated in HTS 2933.49.20.00. This drug contains the quinoline ring system with iodine substitutions, used for treating intestinal amebiasis and classified as a Chapter 29 pharmaceutical compound.
Duty Rate — Canada → United States
110%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• FDA requires IND or NDA for human use; include thyroid toxicity warnings in SDS
• Verify iodine content via HPLC analysis in COA to confirm identity and purity